Targeting the small airways asthma phenotype: If we can reach it, should we treat it?

Annals of Allergy, Asthma and Immunology

Volumn 110, Issue 4, 2013, Pages 233-239

  Lipworth, Brian ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BECLOMETASONE DIPROPIONATE PLUS FORMOTEROL FUMARATE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE PLUS FORMOTEROL FUMARATE; CHLOROFLUOROCARBON; CICLESONIDE; CORTICOSTEROID; FLUNISOLIDE; FLUORINATED HYDROCARBON; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS FORMOTEROL FUMARATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE; FORMOTEROL FUMARATE PLUS MOMETASONE FUROATE; MANNITOL; METHACHOLINE; NITRIC OXIDE; PREDNISOLONE; SALBUTAMOL; TECHNETIUM 99M; ZAFIRLUKAST;

ADD ON THERAPY; AIRWAY RESISTANCE; ASTHMA; BREATH ANALYSIS; DISEASE CONTROL; DRUG ACTIVITY; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG SUBSTITUTION; DRUG TARGETING; DRUG WITHDRAWAL; FIRST PASS EFFECT; FORCED EXPIRATORY VOLUME; FORCED MIDEXPIRATORY FLOW; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LIPOPHILICITY; LOW DRUG DOSE; LUNG FUNCTION TEST; METERED DOSE INHALER; PARTICLE SIZE; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESIDUAL VOLUME; RESPIRATORY TRACT ALLERGY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SMALL AIRWAY DISEASE; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; THREE DIMENSIONAL IMAGING; TOTAL LUNG CAPACITY; UNSPECIFIED SIDE EFFECT;

ADRENAL CORTEX HORMONES; ADRENERGIC BETA-AGONISTS; AIRWAY RESISTANCE; ANTI-ASTHMATIC AGENTS; ASTHMA; CLINICAL TRIALS AS TOPIC; DRUG THERAPY, COMBINATION; HUMANS; HYDROCARBONS, FLUORINATED; NEBULIZERS AND VAPORIZERS; PHENOTYPE; RESPIRATORY FUNCTION TESTS; RESPIRATORY SYSTEM;

EID: 84875427854     PISSN: 10811206     EISSN: 15344436     Source Type: Journal    
DOI: 10.1016/j.anai.2013.02.009     Document Type: Review

References (50)

1. E.D. Bateman, H.A. Boushey, and J. Bousquet Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study Am J Respir Crit Care Med 170 2004 836 844 (Pubitemid 39346477)
2. M. Thomas, J. von Ziegenweidt, A.J. Lee, and D. Price High-dose inhaled corticosteroids versus add-on long-acting beta-agonists in asthma: an observational study J Allergy Clin Immunol 123 2009 116 121 e10
3. Q. Hamid Pathogenesis of small airways in asthma Respiration 84 2012 4 11
4. M. van den Berge, N.H. ten Hacken, E. van der Wiel, and D.S. Postma Treatment of the bronchial tree from beginning to end: targeting small airway inflammation in asthma Allergy 68 2013 16 26
5. J.G. Goldin, D.P. Tashkin, and E.C. Kleerup Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography J Allergy Clin Immunol 104 1999 S258 S267
6. A. Nair, J. Ward, and B.J. Lipworth Comparison of bronchodilator response in patients with asthma and healthy subjects using spirometry and oscillometry Ann Allergy Asthma Immunol 107 2011 317 322
7. P.M. Short, P.A. Williamson, and B.J. Lipworth Sensitivity of impulse oscillometry and spirometry in beta-blocker induced bronchoconstriction and beta-agonist bronchodilatation in asthma Ann Allergy Asthma Immunol 109 2012 412 415
8. W.J. Anderson, E. Zajda, and B.J. Lipworth Are we overlooking persistent small airways dysfunction in community-managed asthma? Ann Allergy Asthma Immunol 109 2012 185 189 e2
9. Y. Shi, A.S. Aledia, and A.V. Tatavoosian Relating small airways to asthma control by using impulse oscillometry in children J Allergy Clin Immunol 129 2012 671 678
10. Y. Shi, A.S. Aledia, S.P. Galant, and S.C. George Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children published online ahead of print J Allergy Clin Immunol November 10, 2012 10.1016/j.jaci.2012.09.022
11. D.R. Rao, J.M. Gaffin, and S.N. Baxi The utility of forced expiratory flow between 25% and 75% of vital capacity in predicting childhood asthma morbidity and severity J Asthma 49 2012 586 592
12. C.S. Farah, G.G. King, and N.J. Brown The role of the small airways in the clinical expression of asthma in adults J Allergy Clin Immunol 129 2012 381 387 87, e1
13. C.S. Farah, G.G. King, and N.J. Brown Ventilation heterogeneity predicts asthma control in adults following inhaled corticosteroid dose titration J Allergy Clin Immunol 130 2012 61 68
14. J.C. in 't Veen, A.J. Beekman, E.H. Bel, and P.J. Sterk Recurrent exacerbations in severe asthma are associated with enhanced airway closure during stable episodes Am J Respir Crit Care Med 161 2000 1902 1906 (Pubitemid 30418127)
15. P. Condorelli, H.W. Shin, A.S. Aledia, P.E. Silkoff, and S.C. George A simple technique to characterize proximal and peripheral nitric oxide exchange using constant flow exhalations and an axial diffusion model J Appl Physiol 102 2007 417 425 (Pubitemid 46089793)
16. P.A. Williamson, K. Clearie, D. Menzies, S. Vaidyanathan, and B.J. Lipworth Assessment of small-airways disease using alveolar nitric oxide and impulse oscillometry in asthma and COPD Lung 189 2011 121 129
17. C.L. Leach, P.J. Kuehl, and R. Chand Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients Ann Allergy Asthma Immunol 108 2012 195 200
18. W.W. Busse, S. Brazinsky, and K. Jacobson Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant J Allergy Clin Immunol 104 1999 1215 1222 (Pubitemid 30004983)
19. M. Yamaguchi, A. Niimi, and T. Ueda Effect of inhaled corticosteroids on small airways in asthma: investigation using impulse oscillometry Pulm Pharmacol Ther 22 2009 326 332
20. M. Berry, B. Hargadon, and A. Morgan Alveolar nitric oxide in adults with asthma: Evidence of distal lung inflammation in refractory asthma Eur Respir J 25 2005 986 991 (Pubitemid 40823772)
21. G. Nicolini, A. Chetta, and A. Simonazzi Both bronchial and alveolar exhaled nitric oxide are reduced with extrafine beclomethasone dipropionate in asthma Allergy Asthma Proc 31 2010 85 90
22. C.M. Robroeks, K.D. van de Kant, and D. van Vliet Comparison of the anti-inflammatory effects of extra-fine hydrofluoroalkane-beclomethasone vs fluticasone dry powder inhaler on exhaled inflammatory markers in childhood asthma Ann Allergy Asthma Immunol 100 2008 601 607 (Pubitemid 351829861)
23. P.A. Williamson, P.M. Short, S. Vaidyanathan, and B.J. Lipworth Inhaled and systemic corticosteroid response in severe asthma assessed by alveolar nitric oxide: a randomized crossover pilot study of add-on therapy Br J Clin Pharmacol 75 2013 93 102
24. H.P. Hauber, M. Gotfried, and K. Newman Effect of HFA-flunisolide on peripheral lung inflammation in asthma J Allergy Clin Immunol 112 2003 58 63 (Pubitemid 36819807)
25. C. Bergeron, H.P. Hauber, and M. Gotfried Evidence of remodeling in peripheral airways of patients with mild to moderate asthma: effect of hydrofluoroalkane-flunisolide J Allergy Clin Immunol 116 2005 983 989 (Pubitemid 41571776)
26. S. Newman, A. Salmon, R. Nave, and A. Drollmann High lung deposition of 99mTc-labeled ciclesonide administered via HFA-MDI to patients with asthma Respir Med 100 2006 375 384 (Pubitemid 43239871)
27. J. Cohen, D.S. Postma, and W.R. Douma Particle size matters: diagnostics and treatment of small airways involvement in asthma Eur Respir J 37 2011 532 540
28. O.J. Dempsey, S.J. Fowler, A. Wilson, G. Kennedy, and B.J. Lipworth Effects of adding either a leukotriene receptor antagonist or low-dose theophylline to a low or medium dose of inhaled corticosteroid in patients with persistent asthma Chest 122 2002 151 159 (Pubitemid 34754155)
29. B.J. Lipworth, P.M. Short, and P.A. Williamson A randomized primary care trial of steroid titration against mannitol in persistent asthma: STAMINA trial Chest 141 2012 607 615
30. D. Price, R.J. Martin, and N. Barnes Prescribing practices and asthma control with hydrofluoroalkane-beclomethasone and fluticasone: a real-world observational study J Allergy Clin Immunol 126 2010 511 518 e1-10
31. N. Barnes, D. Price, and G. Colice Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon- beclometasone: a real-world observational study Clin Exp Allergy 41 2011 1521 1532
32. E.F. Juniper, D.B. Price, and P.A. Stampone Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate Chest 121 2002 1824 1832 (Pubitemid 34634402)
33. P.T. Daley-Yates, A.C. Price, J.R. Sisson, A. Pereira, and N. Dallow Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man Br J Clin Pharmacol 51 2001 400 409 (Pubitemid 32852976)
34. L.I. Harrison, I. Soria, A.C. Cline, and B.P. Ekholm Pharmacokinetic differences between chlorofluorocarbon and chlorofluorocarbon-free metered dose inhalers of beclomethasone dipropionate in adult asthmatics J Pharm Pharmacol 51 1999 1235 1240 (Pubitemid 30006462)
35. A. Nair, D. Menzies, P. Hopkinson, L. McFarlane, and B.J. Lipworth In vivo comparison of the relative systemic bioavailability of fluticasone propionate from three anti-static spacers and a metered dose inhaler Br J Clin Pharmacol 67 2009 191 198
36. A. Allen, P.J. Bareille, and V.M. Rousell Fluticasone furoate, a novel inhaled corticosteroid, demonstrates prolonged lung absorption kinetics in man compared with inhaled fluticasone propionate published online ahead of print Clin Pharmacokinet 2012 10.1007/s40262-012-0021-x
37. S. Pedersen, J. Warner, and U. Wahn Growth, systemic safety, and efficacy during 1 year of asthma treatment with different beclomethasone dipropionate formulations: an open-label, randomized comparison of extrafine and conventional aerosols in children Pediatrics 109 2002 e92
38. F.D. Martinez, V.M. Chinchilli, and W.J. Morgan Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial Lancet 377 2011 650 657
39. W.J. Anderson, L.C. McFarlane, and B.J. Lipworth Prospective follow-up of novel markers of bone turnover in persistent asthmatics exposed to low and high doses of inhaled ciclesonide over 12 months J Clin Endocrinol Metab 97 2012 1929 1936
40. B.J. Lipworth, M.A. Kaliner, and C.F. LaForce Effect of ciclesonide and fluticasone on hypothalamic-pituitary-adrenal axis function in adults with mild-to-moderate persistent asthma Ann Allergy Asthma Immunol 94 2005 465 472 (Pubitemid 40547935)
41. I.M. Adcock, T. Gilbey, C.M. Gelder, K.F. Chung, and P.J. Barnes Glucocorticoid receptor localization in normal and asthmatic lung Am J Respir Crit Care Med 154 3 pt 1 1996 771 782 (Pubitemid 26327304)
42. Q.A. Hamid, J.C. Mak, and M.N. Sheppard Localization of beta 2-adrenoceptor messenger RNA in human and rat lung using in situ hybridization: correlation with receptor autoradiography Eur J Pharmacol 206 1991 133 138
43. O.S. Usmani, M.F. Biddiscombe, and P.J. Barnes Regional lung deposition and bronchodilator response as a function of beta2-agonist particle size Am J Respir Crit Care Med 172 2005 1497 1504 (Pubitemid 43076536)
44. W. De Backer, A. Devolder, and G. Poli Lung deposition of BDP/formoterol HFA pMDI in healthy volunteers, asthmatic, and COPD patients J Aerosol Med Pulm Drug Deliv 23 2010 137 148
45. C.M. Houghton, S.J. Langley, and S.D. Singh Comparison of bronchoprotective and bronchodilator effects of a single dose of formoterol delivered by hydrofluoroalkane and chlorofluorocarbon aerosols and dry powder in a double blind, placebo-controlled, crossover study Br J Clin Pharmacol 58 2004 359 366 (Pubitemid 39312459)
46. N. Scichilone, S. Battaglia, and C. Sorino Effects of extra-fine inhaled beclomethasone/formoterol on both large and small airways in asthma Allergy 65 2010 897 902
47. L. Corda, G.G. Gardenghi, and D. Modina Effects on small airway obstruction of long-term treatments with beclomethasone/formoterol hydrofluoroalkane (metered-dose inhaler) versus fluticasone/salmeterol (dry-powder inhaler) in asthma: a preliminary study Allergy Asthma Proc 32 2011 29 34
48. G. Huchon, H. Magnussen, and A. Chuchalin Lung function and asthma control with beclomethasone and formoterol in a single inhaler Respir Med 103 2009 41 49
49. L. Allegra, G. Cremonesi, and G. Girbino Real-life prospective study on asthma control in Italy: cross-sectional phase results Respir Med 106 2012 205 214
50. C. Terzano, G. Cremonesi, and G. Girbino 1-year prospective real life monitoring of asthma control and quality of life in Italy Respir Res 13 2012 112